Report Detail

Pharma & Healthcare Global Biotech Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4742339
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 131 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Biotech Drug market size was valued at US$ 489570 million in 2025 and is forecast to a readjusted size of US$ 859990 million by 2032 with a CAGR of 8.5% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Biotech Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biotech Drug market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biotech Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biotech Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biotech Drug market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biotech Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biotech Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biotech Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biotech Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biotech Drug, with revenue, gross margin, and global market share of Biotech Drug from 2021 to 2026.
Chapter 3, the Biotech Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biotech Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biotech Drug.
Chapter 13, to describe Biotech Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biotech Drug by Type
    • 1.3.1 Overview: Global Biotech Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biotech Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Interferon
    • 1.3.5 Insulin
    • 1.3.6 Vaccines
    • 1.3.7 Others
  • 1.4 Global Biotech Drug Market by Application
    • 1.4.1 Overview: Global Biotech Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Biotech Drug Market Size & Forecast
  • 1.6 Global Biotech Drug Market Size and Forecast by Region
    • 1.6.1 Global Biotech Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Biotech Drug Market Size by Region, (2021-2032)
    • 1.6.3 North America Biotech Drug Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Biotech Drug Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Biotech Drug Market Size and Prospect (2021-2032)
    • 1.6.6 South America Biotech Drug Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Biotech Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Biotech Drug Product and Solutions
    • 2.1.4 Roche Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Biotech Drug Product and Solutions
    • 2.2.4 Amgen Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Amgen Recent Developments and Future Plans
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Biotech Drug Product and Solutions
    • 2.3.4 AbbVie Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AbbVie Recent Developments and Future Plans
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Biotech Drug Product and Solutions
    • 2.4.4 Sanofi Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sanofi Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Biotech Drug Product and Solutions
    • 2.5.4 Johnson & Johnson Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Biotech Drug Product and Solutions
    • 2.6.4 Pfizer Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Novo Nordisk
    • 2.7.1 Novo Nordisk Details
    • 2.7.2 Novo Nordisk Major Business
    • 2.7.3 Novo Nordisk Biotech Drug Product and Solutions
    • 2.7.4 Novo Nordisk Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novo Nordisk Recent Developments and Future Plans
  • 2.8 Eli Lilly
    • 2.8.1 Eli Lilly Details
    • 2.8.2 Eli Lilly Major Business
    • 2.8.3 Eli Lilly Biotech Drug Product and Solutions
    • 2.8.4 Eli Lilly Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Eli Lilly Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Biotech Drug Product and Solutions
    • 2.9.4 Novartis Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Merck
    • 2.10.1 Merck Details
    • 2.10.2 Merck Major Business
    • 2.10.3 Merck Biotech Drug Product and Solutions
    • 2.10.4 Merck Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Merck Recent Developments and Future Plans
  • 2.11 Biogen
    • 2.11.1 Biogen Details
    • 2.11.2 Biogen Major Business
    • 2.11.3 Biogen Biotech Drug Product and Solutions
    • 2.11.4 Biogen Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Biogen Recent Developments and Future Plans
  • 2.12 Celltrion
    • 2.12.1 Celltrion Details
    • 2.12.2 Celltrion Major Business
    • 2.12.3 Celltrion Biotech Drug Product and Solutions
    • 2.12.4 Celltrion Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Celltrion Recent Developments and Future Plans
  • 2.13 Sobi
    • 2.13.1 Sobi Details
    • 2.13.2 Sobi Major Business
    • 2.13.3 Sobi Biotech Drug Product and Solutions
    • 2.13.4 Sobi Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Sobi Recent Developments and Future Plans
  • 2.14 3SBIO
    • 2.14.1 3SBIO Details
    • 2.14.2 3SBIO Major Business
    • 2.14.3 3SBIO Biotech Drug Product and Solutions
    • 2.14.4 3SBIO Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 3SBIO Recent Developments and Future Plans
  • 2.15 Changchun High Tech
    • 2.15.1 Changchun High Tech Details
    • 2.15.2 Changchun High Tech Major Business
    • 2.15.3 Changchun High Tech Biotech Drug Product and Solutions
    • 2.15.4 Changchun High Tech Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Changchun High Tech Recent Developments and Future Plans
  • 2.16 Kanghong Pharma
    • 2.16.1 Kanghong Pharma Details
    • 2.16.2 Kanghong Pharma Major Business
    • 2.16.3 Kanghong Pharma Biotech Drug Product and Solutions
    • 2.16.4 Kanghong Pharma Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Kanghong Pharma Recent Developments and Future Plans
  • 2.17 Innovent Biologics
    • 2.17.1 Innovent Biologics Details
    • 2.17.2 Innovent Biologics Major Business
    • 2.17.3 Innovent Biologics Biotech Drug Product and Solutions
    • 2.17.4 Innovent Biologics Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Innovent Biologics Recent Developments and Future Plans
  • 2.18 Gan&Lee
    • 2.18.1 Gan&Lee Details
    • 2.18.2 Gan&Lee Major Business
    • 2.18.3 Gan&Lee Biotech Drug Product and Solutions
    • 2.18.4 Gan&Lee Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Gan&Lee Recent Developments and Future Plans
  • 2.19 Tonghua Dongbao
    • 2.19.1 Tonghua Dongbao Details
    • 2.19.2 Tonghua Dongbao Major Business
    • 2.19.3 Tonghua Dongbao Biotech Drug Product and Solutions
    • 2.19.4 Tonghua Dongbao Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Tonghua Dongbao Recent Developments and Future Plans
  • 2.20 United Laboratory
    • 2.20.1 United Laboratory Details
    • 2.20.2 United Laboratory Major Business
    • 2.20.3 United Laboratory Biotech Drug Product and Solutions
    • 2.20.4 United Laboratory Biotech Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 United Laboratory Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biotech Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biotech Drug by Company Revenue
    • 3.2.2 Top 3 Biotech Drug Players Market Share in 2025
    • 3.2.3 Top 6 Biotech Drug Players Market Share in 2025
  • 3.3 Biotech Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Biotech Drug Market: Region Footprint
    • 3.3.2 Biotech Drug Market: Company Product Type Footprint
    • 3.3.3 Biotech Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biotech Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biotech Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biotech Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biotech Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biotech Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Biotech Drug Market Size by Application (2021-2032)
  • 6.3 North America Biotech Drug Market Size by Country
    • 6.3.1 North America Biotech Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biotech Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biotech Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biotech Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biotech Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Biotech Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Biotech Drug Market Size by Country
    • 7.3.1 Europe Biotech Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biotech Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Biotech Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biotech Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biotech Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biotech Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biotech Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biotech Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biotech Drug Market Size by Region
    • 8.3.1 Asia-Pacific Biotech Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Biotech Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biotech Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biotech Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Biotech Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biotech Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biotech Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biotech Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Biotech Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Biotech Drug Market Size by Country
    • 9.3.1 South America Biotech Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biotech Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biotech Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biotech Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biotech Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biotech Drug Market Size by Country
    • 10.3.1 Middle East & Africa Biotech Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biotech Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biotech Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biotech Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biotech Drug Market Drivers
  • 11.2 Biotech Drug Market Restraints
  • 11.3 Biotech Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biotech Drug Industry Chain
  • 12.2 Biotech Drug Upstream Analysis
  • 12.3 Biotech Drug Midstream Analysis
  • 12.4 Biotech Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biotech Drug. Industry analysis & Market Report on Biotech Drug is a syndicated market report, published as Global Biotech Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biotech Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report